Dae Gon Ha
Stock Analyst at Stifel
(2.73)
# 2,052
Out of 4,966 analysts
46
Total ratings
39.47%
Success rate
9.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dae Gon Ha
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals | Reinstates: Buy | $89 | $73.87 | +20.48% | 4 | Aug 11, 2025 | |
| ABEO Abeona Therapeutics | Maintains: Buy | $21 → $20 | $6.83 | +192.83% | 2 | May 16, 2025 | |
| EDIT Editas Medicine | Downgrades: Hold | $11 → $3 | $2.57 | +16.73% | 4 | Dec 13, 2024 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $59 → $74 | $67.67 | +9.35% | 2 | Oct 1, 2024 | |
| FULC Fulcrum Therapeutics | Downgrades: Hold | $22 → $3 | $6.48 | -53.70% | 4 | Sep 12, 2024 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $80 → $64 | $11.36 | +463.63% | 2 | Sep 11, 2024 | |
| KRYS Krystal Biotech | Maintains: Buy | $204 → $220 | $147.70 | +48.95% | 4 | Sep 11, 2024 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $124 → $127 | $29.96 | +323.90% | 2 | May 31, 2024 | |
| RCKT Rocket Pharmaceuticals | Reiterates: Buy | $48 | $3.28 | +1,363.41% | 4 | Sep 13, 2023 | |
| PRME Prime Medicine | Initiates: Buy | $18 | $3.24 | +455.56% | 1 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $7 | $1.74 | +302.30% | 1 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $25 | $103.15 | -75.76% | 4 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 → $16 | $7.59 | +110.80% | 3 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $285 | $12.19 | +2,238.94% | 1 | Sep 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $2.25 | +788.89% | 1 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.37 | - | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $27.57 | - | 1 | Jun 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $8.31 | - | 1 | Jun 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.60 | +650.00% | 1 | Jun 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $600 → $490 | $9.60 | +5,004.17% | 2 | Oct 23, 2017 |
Mirum Pharmaceuticals
Aug 11, 2025
Reinstates: Buy
Price Target: $89
Current: $73.87
Upside: +20.48%
Abeona Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $21 → $20
Current: $6.83
Upside: +192.83%
Editas Medicine
Dec 13, 2024
Downgrades: Hold
Price Target: $11 → $3
Current: $2.57
Upside: +16.73%
Soleno Therapeutics
Oct 1, 2024
Maintains: Buy
Price Target: $59 → $74
Current: $67.67
Upside: +9.35%
Fulcrum Therapeutics
Sep 12, 2024
Downgrades: Hold
Price Target: $22 → $3
Current: $6.48
Upside: -53.70%
Intellia Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $80 → $64
Current: $11.36
Upside: +463.63%
Krystal Biotech
Sep 11, 2024
Maintains: Buy
Price Target: $204 → $220
Current: $147.70
Upside: +48.95%
Ultragenyx Pharmaceutical
May 31, 2024
Maintains: Buy
Price Target: $124 → $127
Current: $29.96
Upside: +323.90%
Rocket Pharmaceuticals
Sep 13, 2023
Reiterates: Buy
Price Target: $48
Current: $3.28
Upside: +1,363.41%
Prime Medicine
Apr 18, 2023
Initiates: Buy
Price Target: $18
Current: $3.24
Upside: +455.56%
Mar 24, 2023
Maintains: Buy
Price Target: $12 → $7
Current: $1.74
Upside: +302.30%
Jun 17, 2022
Maintains: Buy
Price Target: $23 → $25
Current: $103.15
Upside: -75.76%
Nov 15, 2021
Upgrades: Buy
Price Target: $12 → $16
Current: $7.59
Upside: +110.80%
Sep 7, 2021
Initiates: Buy
Price Target: $285
Current: $12.19
Upside: +2,238.94%
May 3, 2021
Initiates: Buy
Price Target: $20
Current: $2.25
Upside: +788.89%
Sep 8, 2020
Downgrades: Neutral
Price Target: n/a
Current: $9.37
Upside: -
Jun 17, 2020
Initiates: Neutral
Price Target: n/a
Current: $27.57
Upside: -
Jun 17, 2020
Initiates: Neutral
Price Target: n/a
Current: $8.31
Upside: -
Jun 17, 2020
Initiates: Buy
Price Target: $12
Current: $1.60
Upside: +650.00%
Oct 23, 2017
Maintains: Outperform
Price Target: $600 → $490
Current: $9.60
Upside: +5,004.17%